Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuta Miyashi

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Cancer Diagnosis & Prognosis|January 5, 2026
Methionine Restriction Must Be Continuously Maintained to Selectively Inhibit Cancer Cells Co-cultured With Normal CellsByung Mo Kang, Qinghong Han, Shukuan Li, et al.
In Vivo (Athens, Greece)|February 27, 2026
Methionine Restriction Alone Induces T-cell-mediated Immunotherapy of Osteosarcoma in a Syngeneic Mouse ModelKohei Mizuta, Yutaro Kubota, Yusuke Aoki, et al.
Anticancer Research|September 26, 2025
Recombinant Methioninase Selectively Eliminates Cancer Cells Co-cultured With Normal Fibroblasts Indicating the High-Precision Efficacy of Targeting Methionine Addiction of CancerByung Mo Kang, Qinghong Han, Shukuan Li, et al.
Cancer Diagnosis & Prognosis|May 4, 2026
Chemotherapy in Combination With Methionine Restriction Induced A Complete Response in a Patient With Recurrent Metastatic Tongue Squamous-Cell CarcinomaTomoyuki Ishiguro, Toshihiko Sato, Qinghong Han, et al.
Anticancer Research|August 28, 2025
Combinations of <i>Salmonella typhimurium</i> A1-R, Recombinant Methioninase, and Chloroquine, Each Targeting Fundamental Cancer Hallmarks, Are Selectively Effective on Colon Cancer Cells Compared to Normal FibroblastsJinsoo Kim, Qinghong Han, Shukuan Li, et al.
Anticancer Research|January 30, 2026
Glutamine Dependence Is Not a Cancer-specific Vulnerability in Contrast to Methionine DependenceYuta Miyashi, Kohei Mizuta, Yohei Asano, et al.
Anticancer Research|December 30, 2025
Methionine Restriction, Not Cysteine Restriction, Is a Cancer-specific VulnerabilityYuta Miyashi, Kohei Mizuta, Yohei Asano, et al.
Anticancer Research|March 27, 2026
The Glucose and Glutamine Requirements of Cancer and Normal Cells Do Not Distinguish Them, in Contrast to Their Methionine Requirement, Suggesting the Warburg Effect Is Not a Cancer ParadigmYuta Miyashi, Kohei Mizuta, Tomoyuki Ishiguro, et al.
Anticancer Research|June 27, 2025
The Combination of the Autophagy Inhibitor Chloroquine and Recombinant Methioninase Has Selective Synergistic Efficacy on Human Colon Cancer Cells But Not on Normal Human FibroblastsYohei Asano, Qinghong Han, Shukuan Li, et al.
In Vivo (Athens, Greece)|June 30, 2026
Synergy of a Low-methionine Diet and Reduced-dose Cisplatinum Eradicates Experimental Lung-cancer Bone Metastases in a Nude-mouse ModelYohei Asano, Kohei Mizuta, Yuta Miyashi, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Cancer Diagnosis & Prognosis|January 5, 2026
Methionine Restriction Must Be Continuously Maintained to Selectively Inhibit Cancer Cells Co-cultured With Normal CellsByung Mo Kang, Qinghong Han, Shukuan Li, et al.
In Vivo (Athens, Greece)|February 27, 2026
Methionine Restriction Alone Induces T-cell-mediated Immunotherapy of Osteosarcoma in a Syngeneic Mouse ModelKohei Mizuta, Yutaro Kubota, Yusuke Aoki, et al.
Anticancer Research|September 26, 2025
Recombinant Methioninase Selectively Eliminates Cancer Cells Co-cultured With Normal Fibroblasts Indicating the High-Precision Efficacy of Targeting Methionine Addiction of CancerByung Mo Kang, Qinghong Han, Shukuan Li, et al.
Cancer Diagnosis & Prognosis|May 4, 2026
Chemotherapy in Combination With Methionine Restriction Induced A Complete Response in a Patient With Recurrent Metastatic Tongue Squamous-Cell CarcinomaTomoyuki Ishiguro, Toshihiko Sato, Qinghong Han, et al.
Anticancer Research|August 28, 2025
Combinations of <i>Salmonella typhimurium</i> A1-R, Recombinant Methioninase, and Chloroquine, Each Targeting Fundamental Cancer Hallmarks, Are Selectively Effective on Colon Cancer Cells Compared to Normal FibroblastsJinsoo Kim, Qinghong Han, Shukuan Li, et al.
Anticancer Research|January 30, 2026
Glutamine Dependence Is Not a Cancer-specific Vulnerability in Contrast to Methionine DependenceYuta Miyashi, Kohei Mizuta, Yohei Asano, et al.
Anticancer Research|December 30, 2025
Methionine Restriction, Not Cysteine Restriction, Is a Cancer-specific VulnerabilityYuta Miyashi, Kohei Mizuta, Yohei Asano, et al.
Anticancer Research|March 27, 2026
The Glucose and Glutamine Requirements of Cancer and Normal Cells Do Not Distinguish Them, in Contrast to Their Methionine Requirement, Suggesting the Warburg Effect Is Not a Cancer ParadigmYuta Miyashi, Kohei Mizuta, Tomoyuki Ishiguro, et al.
Anticancer Research|June 27, 2025
The Combination of the Autophagy Inhibitor Chloroquine and Recombinant Methioninase Has Selective Synergistic Efficacy on Human Colon Cancer Cells But Not on Normal Human FibroblastsYohei Asano, Qinghong Han, Shukuan Li, et al.
In Vivo (Athens, Greece)|June 30, 2026
Synergy of a Low-methionine Diet and Reduced-dose Cisplatinum Eradicates Experimental Lung-cancer Bone Metastases in a Nude-mouse ModelYohei Asano, Kohei Mizuta, Yuta Miyashi, et al.
Pageof 3